Skip to main content
Clinical Trials/IRCT201412097677N3
IRCT201412097677N3
Completed
Phase 2

Comparative study of the efficacy of combination and single therapy of exjade and desferal on ferritin level in patients with major thalassemia

Vice chancellor for research, Kermanshah University of Medical Sciences0 sites90 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
major thalassemia.
Sponsor
Vice chancellor for research, Kermanshah University of Medical Sciences
Enrollment
90
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice chancellor for research, Kermanshah University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Inclusion Criteria: Approved based on clinical symptoms and history of thalassemia and hemoglobin electrophoresis; full cooperation during the study; treatment with deferoxamine subcutaneous injection and ferritin levels below 3000\. Exclusion criteria: Deferiprone gastrointestinal intolerance; leukocytes less than 3,000; severe liver disease; ascites; lack of consent, lack of cooperation in the history of previous treatment regimens (blood transfusion and deferoxamine).

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials